# Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)

> **NCT03701490** · PHASE2 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 213 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Progesterone subcutaneous
- **DRUG:** Progesterone Vaginal Product

## Key facts

- **NCT ID:** NCT03701490
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-12-03
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701490, "Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03701490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*